OrthoPediatrics Corp. (NASDAQ:KIDS) EVP Gregory A. Odle sold 3,750 shares of the business’s stock in a transaction dated Friday, February 19th. The shares were sold at an average price of $56.50, for a total value of $211,875.00. Following the completion of the sale, the executive vice president now owns 72,481 shares in the company, valued at $4,095,176.50. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Shares of OrthoPediatrics stock opened at $56.52 on Tuesday. OrthoPediatrics Corp. has a 52-week low of $32.21 and a 52-week high of $57.42. The stock’s 50-day simple moving average is $46.74 and its 200 day simple moving average is $46.68. The stock has a market capitalization of $1.11 billion, a P/E ratio of -39.25 and a beta of 0.67.
Several institutional investors and hedge funds have recently made changes to their positions in the company. JPMorgan Chase & Co. increased its position in shares of OrthoPediatrics by 17.9% during the fourth quarter. JPMorgan Chase & Co. now owns 5,829 shares of the company’s stock valued at $240,000 after buying an additional 887 shares during the period. Twinbeech Capital LP purchased a new position in shares of OrthoPediatrics during the fourth quarter worth about $373,000. Jane Street Group LLC purchased a new position in shares of OrthoPediatrics during the fourth quarter worth about $201,000. Squarepoint Ops LLC grew its holdings in shares of OrthoPediatrics by 100.7% during the fourth quarter. Squarepoint Ops LLC now owns 14,518 shares of the company’s stock worth $599,000 after purchasing an additional 7,283 shares in the last quarter. Finally, Endurant Capital Management LP grew its holdings in shares of OrthoPediatrics by 52.3% during the fourth quarter. Endurant Capital Management LP now owns 193,008 shares of the company’s stock worth $7,962,000 after purchasing an additional 66,244 shares in the last quarter. Hedge funds and other institutional investors own 71.74% of the company’s stock.
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
Featured Article: What is channel trading?
Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.